Biotech Pharmaceutical
Delmont Laboratories, Inc. in a privately help company who developed Staphage Lysate (SPL), which is a highly effective immunotherapeutic when used concurrently with or as a follow-up to antibiotics in the treatment of idiopathic recurrent canine pyoderma.